Advertisement

Most Recent

image: Opinion: Public Data, Private Concerns

Opinion: Public Data, Private Concerns

By | May 20, 2015

Research participants aren’t always clear on open data policies when consenting to studies.

0 Comments

image: Opinion: Upgrading Cancer Prevention

Opinion: Upgrading Cancer Prevention

By | April 1, 2015

Preemptive detection and intervention will be key to easing the growing burden of cancer, particularly in developing countries.

1 Comment

image: Opinion: #IceBucketChallenge, Investing Well

Opinion: #IceBucketChallenge, Investing Well

By | September 10, 2014

Hundreds of thousands participated in the ALS campaign that went viral, but how are they supposed to decide where to donate?

4 Comments

image: Opinion: The Murky World of Medical Ethics

Opinion: The Murky World of Medical Ethics

By | August 7, 2014

Why are researchers still denying some study participants potentially life-saving therapies?

0 Comments

image: Opinion: Thwarting Medical Tourism

Opinion: Thwarting Medical Tourism

By | June 17, 2014

It’s time to take a strong stance against unregistered cellular therapies, which can undermine legitimate research efforts.

0 Comments

image: Opinion: Pairing Discovery with Regulatory Rigor

Opinion: Pairing Discovery with Regulatory Rigor

By | May 13, 2014

To move cell-based therapies into the clinic, academic researchers may benefit by consulting researchers outside of academia and the biopharma industry.

0 Comments

image: Opinion: Overcoming Cancer’s Complexities

Opinion: Overcoming Cancer’s Complexities

By , , and | April 11, 2014

Considering “targeted therapeutics” in the face of intra-patient heterogeneity. 

2 Comments

image: Opinion: Translational Biotechnology

Opinion: Translational Biotechnology

By | February 17, 2014

Regulators must consider both the promise and potential pitfalls of new technologies when determining whether to move them into clinical trials.

0 Comments

image: Opinion: Of Mice and Men

Opinion: Of Mice and Men

By | December 3, 2013

Researchers scramble to put mouse cancer models on solid footing.

1 Comment

image: Opinion: How HIV Became Positive

Opinion: How HIV Became Positive

By | September 17, 2013

Immunotherapies, such as the re-engineered T cells that last year saved a 7-year-old girl’s life, continue to show promise as cancer treatments.

1 Comment

Advertisement

Popular Now

  1. Opinion: Making Progress by Slowing Down
  2. A Case of Sexual Ambiguity, 1865
    Foundations A Case of Sexual Ambiguity, 1865

    This year marks the 150th anniversary of an autopsy report describing the first known case of a sexual development disorder.

  3. Influential Cancer Biologist Dies
  4. Image of the Day: Colorful Corn
Advertisement
Advertisement
Life Technologies